Atrial Fibrillation
Conditions
Brief summary
Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.
Detailed description
This randomized clinical trial will evaluate whether self-screening for AF with the ECG247 patch monitor will reduce AF-related morbidity.
Interventions
DIAGNOSTIC_TESTLong-term continuous ECG monitoring
Long-term continuous ECG monitoring with ECG247 Smart Heart Sensor
Sponsors
Sorlandet Hospital HF
Haukeland University Hospital
St. Olavs Hospital
University Hospital of North Norway
Oslo University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Intervention model description
Participants will be randomized to screening with continuous ECG screening for 3-7 days, or control/standard of care
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age ≥65 years and minimum one other risk factor for stroke according to the CHA2DS2-VASc risk score: Age ≥75 years, Diabetes, Heart failure, Hypertension, Previous stroke/TIA and/or Vascular disease * Informed consent for participation
Exclusion criteria
* History of AF (self-reported) * Use of anticoagulation therapy * Pacemaker/CRT device * No smart phone
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stroke | 5 years | percent per year |
Countries
Norway
Outcome results
None listed